Corcept Therapeutics
CORT
CORT
190 hedge funds and large institutions have $1.61B invested in Corcept Therapeutics in 2017 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 75 increasing their positions, 50 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
2% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 42
1% more funds holding
Funds holding: 189 → 190 (+1)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
190
Holding in Top 10
5
Calls
$11.5M
Puts
$8.91M
Top Buyers
| 1 | +$65.8M | |
| 2 | +$56.6M | |
| 3 | +$34.3M | |
| 4 |
Renaissance Technologies
New York
|
+$23.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$16.8M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$8.86M | |
| 3 | -$5.51M | |
| 4 |
Two Sigma Investments
New York
|
-$4.21M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$4.03M |